Intravenous Solutions Market Research Report from RI Technologies Explores Key Strategic Developments

Premier Source of Biotechnology and Healthcare Market Research Reports

Light and portable injection devices have become handy as patients can now receive intravenous treatments in doctor’s clinics or even in their own homes.

According to hospital supply companies and nutritionists, almost 80% of patients are deprived of the beneficial effects that could be gained from a wider use of existing intravenous nutrition.”
— Anasuya Vemuri

HYDERABAD, TELANGANA, INDIA, June 2, 2015 / -- Intravenous Solutions Market Research Report from RI Technologies covers the types of Intravenous Solutions and the various nutrients present in Intravenous Solutions in the market. The types of Intravenous Solutions covered include Partial Parenteral Nutrition and Total Parenteral Nutrition. The nutrients present in Intravenous Solutions include Carbohydrates, Salt and Electrolytes, Minerals and Vitamins, Amino Acids and Other (such as Fat Emulsions, Plasma extenders, Antibiotics and IVIG). The report provides an in depth analysis of each of the types and nutrients by their respective categories. The study includes estimates and projections for the total global Intravenous Solutions market and also key regional markets that include North America, Europe, Asia-Pacific and Rest of World. Estimates and projections are illustrated graphically. Business profiles of 15 major companies are discussed in the report. The report serves as a guide to global Intravenous Solutions industry, as it covers more than 150 companies that are engaged in the development and supply of Intravenous Solutions products and services. Information related to recent product releases, product developments, partnerships, collaborations, and mergers and acquisitions is also covered in the report.

The market research report on Intravenous Solutions is available at

This report may help Strategists, Investors, Laboratories, Contract Research Organizations, Biotechnology & Healthcare Companies, Academic Professionals, Drug Approval Authorities, and Other Organizations to -
-Identify Market Opportunities
-Review and Analyze Global and Regional Markets
-Gauge Market Potential for your Products
-Identify Competition
-Use Market Research for exploring new areas
-Acquire Meaningful Guidelines for Strategic Planning
-Gear up for Market Entry
-Get Actionable Information

When IV solutions are produced locally in medically emerging countries, the resulting return on initial investments can be quite small. It is estimated that profitability would stand at only 50% of the total production capacity. The production costs that are incurred in developing IV solutions are 45% to 65% lower than the existing market price for primary product lines. These estimates are based on U.S. cost figures. When the U.S. system of calculation is used, both direct and indirect labor costs are the largest cost factors. However, in developing nations, the labor cost is relatively low and the cost of IV solutions is much higher. Therefore, the actual production cost can be estimated to be 60% to 90% lower than the market price of the product. There is a very high demand for IV solutions. Therefore, even if a situation arises in which production is more than the local demand, there are still excellent prospects of making national sales as well as sales through exports. The raw materials that are required to produce IV solutions are easy to procure as they are readily available in local markets.

The United States leads the global market (about 51% of global market share) for Intravenous Solutions. Due to the cost advantage and rapid increase in population, Asia-Pacific is the fastest growing market for Intravenous Solutions. Asia-Pacific and Rest of World are expected to gain significant market shares in the coming years.

There are certain triggers that drive the growth in the global market. Some of these drivers are population growth and the continuous upgradation of health care delivery mechanisms. IV infusion therapy is increasingly playing a vital role in health care treatment modalities. This is because recent innovations in the field of antibiotics and other medications used in medical spheres such as chemotherapy, burn centers and renal/peritoneal dialysis centers support the use of intravenous solutions. Key suppliers of nutritional intravenous solutions in international markets have also developed techniques of pre-mixing nutrients that were formerly given separately to patients. Earlier pre-mixed intravenous solutions were developed for the convenience they offered. Now the question of cost has been brought into the equation. The changes in Government policies have also facilitated the development of light and portable injection devices. These are handy as patients can now receive intravenous treatments in doctor’s clinics or even in their own homes.

About RI Technologies

RI Technologies,, is a premier market research provider. The company believes in pure research that will trigger action for immediate customer needs rather than plain reporting of data. The reports provide strategic information tools that help to probe into and support critical business decisions. RI Technologies believes in broadening the value of market research obtained through several dedicated streams of information. Investment banks, companies, management consultants, trade associations, corporate executives, business analysts, libraries, universities, and business schools stand to benefit from RI Technologies' unique market research reports.

To order this report, please contact us. You may also explore customized research services on Intravenous Solutions with RI Technologies.

Anasuya Vemuri
RI Technologies
+91 9676994272

Anasuya Vemuri
RI Technologies
+91 9676994272
email us here

EIN Presswire does not exercise editorial control over third-party content provided, uploaded, published, or distributed by users of EIN Presswire. We are a distributor, not a publisher, of 3rd party content. Such content may contain the views, opinions, statements, offers, and other material of the respective users, suppliers, participants, or authors.